Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INFLASEP: PET Imaging of Inflammation in Progressive MS
NCT02305264Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Mar 2012
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of DPA-714 in multiple sclerosis (MS), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Whole brain Binding Potential (BP) of 18F-DPA-714 at Day 0. Started Mar 2012; status: completed.
02
Drugs
DPA-714
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT02305264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02305264.